• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄膜黑色素瘤中的HLA表达与肿瘤浸润免疫细胞

HLA expression and tumor-infiltrating immune cells in uveal melanoma.

作者信息

de Waard-Siebinga I, Hilders C G, Hansen B E, van Delft J L, Jager M J

机构信息

Department of Ophthalmology, University Hospital Leiden, The Netherlands.

出版信息

Graefes Arch Clin Exp Ophthalmol. 1996 Jan;234(1):34-42. doi: 10.1007/BF00186516.

DOI:10.1007/BF00186516
PMID:8750848
Abstract

BACKGROUND

In uveal melanoma, both the amount of tumor-infiltrating cells and the level of expression of HLA antigens are quite variable. We hypothesized that low levels of HLA expression lead to a lack of antigen presentation, which might prevent proper immunologic recognition of the tumor. This lack of recognition might subsequently lead to low levels of tumor-infiltrating cells.

METHODS

To test this hypothesis, we determined the type and number of tumor-infiltrating cells in tumor sections from 24 uveal melanomas. We applied monoclonal antibodies directed against different types of immune cells and compared the results with the expression of HLA class I and class II antigens on the tumor cells.

RESULTS

Infiltrating immune cells were observed in all uveal melanomas (although in small amounts), with a predominance of T lymphocytes. Significant positive correlations were observed between the number of CD3+ cells (T lymphocytes) and monomorphic HLA class I expression, allele-specific HLA-A2 and Bw4 expression, and HLA class II expression. Furthermore, the number of CD4+ cells (T helper cells, monocytes/ macrophages) and of CD11b+ cells (monocytes/macrophages) was significantly correlated with the level of monomorphic HLA class I expression.

CONCLUSION

These data support our hypothesis that low levels of HLA expression (and therefore a lack of presentation of tumor-specific antigens) may lead to a low level of tumor infiltrate.

摘要

背景

在葡萄膜黑色素瘤中,肿瘤浸润细胞的数量和HLA抗原的表达水平差异很大。我们推测HLA低表达导致抗原呈递缺乏,这可能会阻止对肿瘤的正常免疫识别。这种识别缺乏可能随后导致肿瘤浸润细胞水平降低。

方法

为了验证这一假设,我们确定了24例葡萄膜黑色素瘤肿瘤切片中肿瘤浸润细胞的类型和数量。我们应用针对不同类型免疫细胞的单克隆抗体,并将结果与肿瘤细胞上HLA I类和II类抗原的表达进行比较。

结果

在所有葡萄膜黑色素瘤中均观察到浸润性免疫细胞(尽管数量较少),以T淋巴细胞为主。观察到CD3 +细胞(T淋巴细胞)的数量与单态性HLA I类表达、等位基因特异性HLA - A2和Bw4表达以及HLA II类表达之间存在显著正相关。此外,CD4 +细胞(辅助性T细胞、单核细胞/巨噬细胞)和CD11b +细胞(单核细胞/巨噬细胞)的数量与单态性HLA I类表达水平显著相关。

结论

这些数据支持我们的假设,即HLA低表达(因此缺乏肿瘤特异性抗原呈递)可能导致肿瘤浸润水平降低。

相似文献

1
HLA expression and tumor-infiltrating immune cells in uveal melanoma.葡萄膜黑色素瘤中的HLA表达与肿瘤浸润免疫细胞
Graefes Arch Clin Exp Ophthalmol. 1996 Jan;234(1):34-42. doi: 10.1007/BF00186516.
2
HLA expression in a primary uveal melanoma, its cell line, and four of its metastases.原发性葡萄膜黑色素瘤、其细胞系及其四处转移灶中的人类白细胞抗原(HLA)表达情况。
Br J Ophthalmol. 1997 Nov;81(11):989-93. doi: 10.1136/bjo.81.11.989.
3
Infiltrating lymphocytes and antigen expression in uveal melanoma.葡萄膜黑色素瘤中的浸润淋巴细胞和抗原表达
Ophthalmic Res. 1992;24(1):20-6. doi: 10.1159/000267140.
4
Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.3号染色体单体性与炎症表型在葡萄膜黑色素瘤中共同出现。
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):505-10. doi: 10.1167/iovs.07-0786.
5
Major histocompatibility antigens and antigen-processing molecules in uveal melanoma.葡萄膜黑色素瘤中的主要组织相容性抗原和抗原加工分子
Clin Cancer Res. 2003 Sep 15;9(11):4159-64.
6
HLA antigen expression on uveal melanoma cells in vivo and in vitro.葡萄膜黑色素瘤细胞在体内和体外的HLA抗原表达。
Hum Immunol. 1995 Oct;44(2):111-7. doi: 10.1016/0198-8859(95)00083-g.
7
Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma.不同亚群的肿瘤浸润淋巴细胞与黑色素瘤中的巨噬细胞浸润和单体型 3 相关。
Invest Ophthalmol Vis Sci. 2012 Aug 9;53(9):5370-8. doi: 10.1167/iovs.11-9280.
8
Expression of classic and nonclassic HLA class I antigens in uveal melanoma.葡萄膜黑色素瘤中经典和非经典HLA I类抗原的表达
Invest Ophthalmol Vis Sci. 2003 May;44(5):2016-9. doi: 10.1167/iovs.02-0810.
9
Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.转移性宫颈癌细胞改变HLA表达作为免疫监视受损的一个因素。
Gynecol Oncol. 1995 Jun;57(3):366-75. doi: 10.1006/gyno.1995.1156.
10
Decreased expression of HLA class II antigens on human uveal melanoma cells after in vivo X-ray irradiation.
Am J Ophthalmol. 1988 Jan 15;105(1):78-86. doi: 10.1016/0002-9394(88)90125-0.

引用本文的文献

1
Transvitreal Retinochoroidal Biopsies of Primary Uveal Melanoma Reveal an Association of Low HLA Class I and High NK Cell Abundance in Low-Risk Disease.原发性葡萄膜黑色素瘤的经玻璃体视网膜脉络膜活检显示,低风险疾病中低HLA I类分子与高自然杀伤细胞丰度之间存在关联。
Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):24. doi: 10.1167/iovs.66.2.24.
2
Identification of feature genes and molecular mechanisms involved in cell communication in uveal melanoma through analysis of single‑cell sequencing data.通过单细胞测序数据分析鉴定葡萄膜黑色素瘤细胞通讯中涉及的特征基因和分子机制。
Oncol Lett. 2024 Aug 20;28(5):503. doi: 10.3892/ol.2024.14636. eCollection 2024 Nov.
3

本文引用的文献

1
MALIGNANT MELANOMA OF CHOROID. REPORT OF A CASE WITH CLINICAL HISTORY OF 36 YEARS AND FOLLOW UP OF 32 YEARS.脉络膜恶性黑色素瘤。1例36年临床病史及32年随访报告。
Arch Ophthalmol. 1965 Feb;73:198-9. doi: 10.1001/archopht.1965.00970030200009.
2
Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma.葡萄膜恶性黑色素瘤中浸润淋巴细胞的免疫组织化学
Invest Ophthalmol Vis Sci. 1993 Jul;34(8):2603-6.
3
The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma.
The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma.
免疫检查点 VISTA 与恶性葡萄膜黑色素瘤患者的预后相关。
Front Immunol. 2023 Aug 18;14:1225140. doi: 10.3389/fimmu.2023.1225140. eCollection 2023.
4
Identification of co-expressed gene networks promoting CD8 T cell infiltration and having prognostic value in uveal melanoma.鉴定促进 CD8 T 细胞浸润并具有葡萄膜黑色素瘤预后价值的共表达基因网络。
BMC Ophthalmol. 2023 Aug 10;23(1):354. doi: 10.1186/s12886-023-03098-7.
5
Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma.小眼畸形相关转录因子:葡萄膜黑色素瘤的分化标志物。
Int J Mol Sci. 2023 May 16;24(10):8861. doi: 10.3390/ijms24108861.
6
Tumor-Infiltrating T Cells Can Be Expanded Successfully from Primary Uveal Melanoma after Separation from Their Tumor Environment.肿瘤浸润性T细胞从原发性葡萄膜黑色素瘤中分离出来并脱离其肿瘤环境后能够成功扩增。
Ophthalmol Sci. 2022 Mar 1;2(2):100132. doi: 10.1016/j.xops.2022.100132. eCollection 2022 Jun.
7
Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal Melanoma.在葡萄膜黑色素瘤中,当存在浸润淋巴细胞时,组蛋白去乙酰化酶1、3和8的表达上调。
Cancers (Basel). 2021 Aug 18;13(16):4146. doi: 10.3390/cancers13164146.
8
MiRNAs Correlate with HLA Expression in Uveal Melanoma: Both Up- and Downregulation Are Related to Monosomy 3.微小RNA与葡萄膜黑色素瘤中的HLA表达相关:上调和下调均与3号染色体单体性有关。
Cancers (Basel). 2021 Aug 10;13(16):4020. doi: 10.3390/cancers13164020.
9
Analysis of Ferroptosis-Mediated Modification Patterns and Tumor Immune Microenvironment Characterization in Uveal Melanoma.葡萄膜黑色素瘤中铁死亡介导的修饰模式分析及肿瘤免疫微环境特征
Front Cell Dev Biol. 2021 Jul 27;9:685120. doi: 10.3389/fcell.2021.685120. eCollection 2021.
10
Bioinformatic Analysis Reveals Central Role for Tumor-Infiltrating Immune Cells in Uveal Melanoma Progression.生物信息学分析揭示肿瘤浸润免疫细胞在葡萄膜黑色素瘤进展中的核心作用。
J Immunol Res. 2021 Jun 11;2021:9920234. doi: 10.1155/2021/9920234. eCollection 2021.
Am J Clin Pathol. 1994 Jan;101(1):5-12. doi: 10.1093/ajcp/101.1.5.
4
Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28.BB7.2的部分纯化及某些特性。一种对HLA - A2和HLA - A28变体具有特异性的细胞毒性单克隆抗体。
Hum Immunol. 1981 Dec;3(4):277-99. doi: 10.1016/0198-8859(81)90065-3.
5
HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes.人类白细胞抗原-DC抗原可作为人类细胞毒性T淋巴细胞的识别元件。
Eur J Immunol. 1984 Apr;14(4):299-304. doi: 10.1002/eji.1830140404.
6
Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells.手术切除并培养的乳腺癌细胞中HLA和肿瘤相关抗原表达的异质性。
Cancer Res. 1983 Feb;43(2):660-8.
7
Monoclonal antibody to HLA-A3.抗HLA - A3单克隆抗体
Hybridoma. 1982;1(2):87-90. doi: 10.1089/hyb.1.1982.1.87.
8
Detection of a novel human class II HLA antigen.一种新型人类II类HLA抗原的检测
Nature. 1983;304(5924):358-61. doi: 10.1038/304358a0.
9
Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.由15种抗DR或与人类DR分子交叉反应的同种异体抗Iak单克隆抗体(mAb)所定义的不同HLA - DR表位和不同的HLA - Dr分子家族。I. mAb细胞表面固定的交叉抑制研究以及mAb与通过第一种mAb固定在固相上的去污剂溶解的HLA分子的差异结合。
Eur J Immunol. 1983 Feb;13(2):106-11. doi: 10.1002/eji.1830130205.
10
Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma.良性痣细胞增生和恶性黑色素瘤中的主要组织相容性抗原与单核炎性浸润
J Immunol. 1982 Dec;129(6):2808-15.